Freed $99 Distribution Strategy

Diving deeper into

Freed

Company Report
This pricing strategy positions them as one of the most affordable AI medical scribe solutions in the market
Analyzed 5 sources

Freed is using price as distribution, not just as positioning. At $99 per clinician per month, the product is cheap enough for a solo doctor or a five doctor clinic to buy on a card, without waiting for an IT committee or annual budget cycle. That matters in medical scribing because enterprise rivals usually win through deep EHR integration and hospital sales, but they also carry much higher per seat pricing and much slower sales motion.

  • The practical tradeoff is smaller contracts in exchange for faster adoption. Freed reached about 12,000 clinicians and $13M ARR by August 2024 with roughly $1K ACV, showing that many small accounts can add up quickly even without large health system deals.
  • The price gap is real. Comparable enterprise focused scribes like Abridge, Ambience, Suki, and Nuance have been framed in the $300 to $600 per month range, with Abridge around $500 per clinician per month as it bundles tighter workflow and billing integration for hospitals.
  • That low price also matches the buyer. In small practices, the clinician is often the user and the decision maker. In hospitals, purchases run through compliance, business associate agreements, and EHR teams, which favors vendors with deeper integrations over vendors with the lowest sticker price.

The next step is moving from cheap note capture into more embedded workflows like pre charting, coding, and payments. If Freed can keep its self serve entry point while adding products that touch revenue and clinician workflow more directly, it can raise revenue per clinician without giving up the speed advantage that made the $99 wedge work.